Congress Presentations
Stay informed about the latest scientific and medical research from Axsome.
SLEEP 2025
Seattle, WA | June 08 - 11, 2025
AXS-12 | Narcolepsy
Plenary Presentation: Residual Symptom Burden in Patients With Narcolepsy Satisfied With Treatment: Subgroup Analysis From the CRESCENDO Survey
AXS-12 | Narcolepsy
Residual Symptom Burden in Patients With Narcolepsy Satisfied With Treatment: Subgroup Analysis From the CRESCENDO Survey
AXS-12 | Narcolepsy
Plenary Presentation: Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results from the Phase 3 SYMPHONY Trial
AXS-12 | Narcolepsy
Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results from the Phase 3 SYMPHONY Trial
AXS-12 | Narcolepsy
ENCORE: Topline Results of a Phase 3 Open-label Extension and Randomized-Withdrawal Study of AXS-12 in Narcolepsy
Sunosi® | Excessive Daytime Sleepiness
Effects of Solriamfetol on Neuropsychological Outcomes in Patients with Obstructive Sleep Apnea in the Real-World SURWEY Study
Sunosi® | Excessive Daytime Sleepiness
Real-World Use of Solriamfetol for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea in the US
